Grants and Contributions:
Title:
Verification of ProTrap XG Performance for Proteomic Analysis of Clinical Samples
Agreement Number:
976659
Agreement Value:
$60,068.00
Agreement Date:
Aug 1, 2021 - Mar 25, 2022
Description:
Perform a proteomic analysis of blood from breast cancer patients in order to demonstrate and verify the utility of Proteoform Scientific’s ProTrap XG for proteomic biomarker analysis.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Halifax, Nova Scotia, CA B3H 0A8
Reference Number:
172-2021-2022-Q2-976659
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
758439715
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 53 days.
Amendment Date
Dec 3, 2021
Recipient's Legal Name:
Proteoform Scientific Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: